Allergy Therapeutics AGYTF Stock
Allergy Therapeutics Price Chart
Allergy Therapeutics AGYTF Financial and Trading Overview
| Allergy Therapeutics stock price | 0.13 USD |
| Previous Close | 0.11 USD |
| Open | 0.11 USD |
| Bid | 0.13 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.11 - 0.11 USD |
| 52 Week Range | 0.09 - 0.11 USD |
| Volume | 15K USD |
| Avg. Volume | 7 USD |
| Market Cap | 696.58M USD |
| Beta (5Y Monthly) | 0.891 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AGYTF Valuation Measures
| Enterprise Value | 692.23M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 12.157962 |
| Price/Book (mrq) | 81.59995 |
| Enterprise Value/Revenue | 12.082 |
| Enterprise Value/EBITDA | -21.902 |
Trading Information
Allergy Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.891 |
| 52-Week Change | 29.41% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 0.11 USD |
| 52 Week Low | 0.09 USD |
| 50-Day Moving Average | 0.11 USD |
| 200-Day Moving Average | 0.1 USD |
AGYTF Share Statistics
| Avg. Volume (3 month) | 7 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 6.33B |
| Float | 703.44M |
| Short Ratio | N/A |
| % Held by Insiders | 88.42% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | -84.084% |
| Operating Margin (ttm) | -31.35% |
| Gross Margin | 52.21% |
| EBITDA Margin | -55.16% |
Management Effectiveness
| Return on Assets (ttm) | -29.63% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 57.29M USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | 6.60% |
| Gross Profit (ttm) | 29.92M USD |
| EBITDA | -31605000 USD |
| Net Income Avi to Common (ttm) | -48175000 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.08M USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 26.75M USD |
| Total Debt/Equity (mrq) | 629.58 USD |
| Current Ratio (mrq) | 1.132 |
| Book Value Per Share (mrq) | 0.00134804 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -32523000 USD |
| Levered Free Cash Flow (ttm) | -24169124 USD |
Profile of Allergy Therapeutics
| Country | United States |
| State | N/A |
| City | Worthing |
| Address | Dominion Way |
| ZIP | BN14 8SA |
| Phone | 44 1903 844 700 |
| Website | https://www.allergytherapeutics.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 584 |
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen; and VLP Peanut, a short-course peanut allergy vaccine. Allergy Therapeutics plc was founded in 1998 and is headquartered in Worthing, the United Kingdom.
Q&A For Allergy Therapeutics Stock
What is a current AGYTF stock price?
Allergy Therapeutics AGYTF stock price today per share is 0.13 USD.
How to purchase Allergy Therapeutics stock?
You can buy AGYTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Allergy Therapeutics?
The stock symbol or ticker of Allergy Therapeutics is AGYTF.
Which industry does the Allergy Therapeutics company belong to?
The Allergy Therapeutics industry is Drug Manufacturers - Specialty & Generic.
How many shares does Allergy Therapeutics have in circulation?
The max supply of Allergy Therapeutics shares is 6.33B.
What is Allergy Therapeutics Price to Earnings Ratio (PE Ratio)?
Allergy Therapeutics PE Ratio is now.
What was Allergy Therapeutics earnings per share over the trailing 12 months (TTM)?
Allergy Therapeutics EPS is -0.01 USD over the trailing 12 months.
Which sector does the Allergy Therapeutics company belong to?
The Allergy Therapeutics sector is Healthcare.